ISOLO

Welcome to the Brand page for “ISOLO”, which is offered here for Providing medical and pharmaceutical information to patients and healthcare practitioners, providing medical information regarding hemolysis and the risk of occurrence in and the treatment of certain patients undergoing human intravenous immunoglobulin therapy and providing information relating to the therapeutic properties of pharmaceuticals for the treatment of hemolysis;.

Its status is currently believed to be active. Its class is unavailable. “ISOLO” is believed to be currently owned by “CSL BEHRING AG”.